Dr. Jeffrey Scott Weinstein, MD

Dr. Weinstein practices at Methodist Medical Group in Dallas, Texas.

Dr. Weinstein's NPI, 1336109735, was assigned on March 28, 2006. Dr. Weinstein graduated from UT Southwestern Medical Center in 1988. Dr. Weinstein holds Texas license H7362.

Dr. Weinstein's primary practice is Methodist Medical Group, at 3400 W Wheatland Rd, Dallas, TX 75237 in Dallas County. The practice phone is (214) 884-4700.

Dr. Weinstein's primary practice is Methodist Medical Group in Dallas, Texas. Dr. Weinstein is also affiliated with Methodist Dallas Medical Center. The medical group on file is Methodist Medical Group. Dmand AI also links Dr. Weinstein to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weinstein practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Weinstein's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Weinstein's licenses on file in 2 states: Texas and Minnesota.

Dmand AI lists cirrhosis of the liver, colonoscopy, fatty liver, hepatitis c and upper GI endoscopy among the conditions Dr. Weinstein treats.

CMS data shows 638 Medicare services from Dr. Weinstein across 11 procedure codes in 2024, for 302 Medicare patients. Medicare paid $59,523 for them.

CMS counts 302 Medicare patients who saw Dr. Weinstein in 2024. The largest group is 65 to 74, with 196 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Weinstein's median patient age at 67, with 51% women.

In 2024, Dr. Weinstein wrote 1,842 Medicare Part D claims for 265 patients. 88% of them were for generic drugs. CMS names the drug for 1,573 of them, across 36 drugs with 11 or more claims each, at $967,525 in total drug cost. In 2023, CMS named 1,388 claims across 32 drugs.

Dr. Weinstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Weinstein as offering telehealth. CMS counts 24 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Weinstein, more than 52% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Weinstein. The most frequent topics are Liver Transplantation, Genotype and Immunosuppressive Agents. Dr. Weinstein has published most often in Liver Transpl. Dr. Weinstein's most frequent co-authors are Goran B. G. Klintmalm, MD, Srinath Chinnakotla, MD and William Dee Dockery, MD.

CMS Open Payments shows 530 general payments to Dr. Weinstein from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. Gilead Sciences, Inc. paid the most, $6,078.

Dmand AI lists 3 awards for Dr. Weinstein, most recently Regional Top Doctor in 2014.

Dr. Weinstein graduated from UT Southwestern Medical Center in 1988. Dr. Weinstein is a member of ACP.

Dr. Weinstein is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.